What Sanofi Might Buy With Its Regeneron Windfall

[cafead]

via Sanofi is about to have $11.7 billion burning a hole in its pocket. What might it buy?

Days after the French drug giant announced that it would sell its stake in the biotech company Regeneron Pharmaceuticals (ticker: REGN), speculation is growing on whether the company might pursue an acquisition or two in the coming months.

article source

 

[anonymous]

Sanofi can only be successful if they co- market drug with another company. Sanofi hasn't launched a successful drug in 20 years . Anything that made money was a co- market Plavix with BMS,Lovenox was Aventis before merger and Lantus. It's a long list. Sanofi can't pick a winner. They will only buy something that currently has a track record behind it as Sanofi can't market a drug on their own.